Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Perspective Therapeutics Stock News

CATXAMEX

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$3.76

0.143.87%

At close: -

$3.76

0.000.00%

After Hours: 6:02 PM EDT

Perspective Therapeutics (CATX) Forecast

News

Earnings Perspective Therapeutics (CATX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Perspective Therapeutics Stock News | AMEX:CATX | Benzinga

Get the latest news on Perspective Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Perspective Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, June 23, 2025

B. Riley Securities Maintains Buy on Perspect...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Perspective ...
Benzinga Newsdesk
Reported Saturday, Perspective Therapeutics O...
Benzinga Newsdesk

Tuesday, June 03, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Perspective Therapeutics shares are trading h...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Perspecti...
Benzinga Newsdesk

Friday, May 30, 2025

Perspective Therapeutics Reveals New Interim ...
Benzinga Newsdesk

Wednesday, May 14, 2025

Truist Securities Maintains Buy on Perspectiv...
Benzinga Newsdesk

Monday, May 12, 2025

Perspective Therapeutics Q1 EPS $(0.25) Beats...
Benzinga Newsdesk
Earnings Scheduled For May 12, 2025
Benzinga Insights

Tuesday, April 29, 2025

Perspective Therapeutics Announces First Pati...
Benzinga Newsdesk

Friday, April 11, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Perspective Therapeutics Doses First Patient ...
Benzinga Newsdesk

Monday, April 07, 2025

Truist Securities Maintains Buy on Perspectiv...
Benzinga Newsdesk

Monday, March 31, 2025

HC Wainwright & Co. Reiterates Buy on Perspec...
Benzinga Newsdesk

Thursday, March 27, 2025

RBC Capital Maintains Outperform on Perspecti...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Perspective ...
Benzinga Newsdesk

Wednesday, March 26, 2025

Perspective Therapeutics FY 2024 GAAP EPS $(1...
Benzinga Newsdesk
Earnings Scheduled For March 26, 2025
Benzinga Insights

Wednesday, March 19, 2025

HC Wainwright & Co. Reiterates Buy on Perspec...
Benzinga Newsdesk

Monday, March 17, 2025

Perspective, Therapeutics Has Dosed The First...
Benzinga Newsdesk

Thursday, March 13, 2025

Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst
Vandana Singh
HC Wainwright & Co. Initiates Coverage On Per...
Benzinga Newsdesk

Friday, March 07, 2025

Scotiabank Initiates Coverage On Perspective ...
Benzinga Newsdesk

Friday, January 24, 2025

Perspective Therapeutics Touts Encouraging Updated Data From Gastrointestinal Cancer Trial, Stock Soars
Vandana Singh
Perspective Therapeutics Announced Updated In...
Benzinga Newsdesk

Wednesday, January 22, 2025

Perspective Therapeutics Announced That An Ab...
Benzinga Newsdesk

Tuesday, January 14, 2025

RBC Capital Reiterates Outperform on Perspect...
Benzinga Newsdesk

Monday, January 13, 2025

Perspective Therapeutics Announced Clinical U...
Benzinga Newsdesk

Monday, January 06, 2025

Perspective Therapeutics Appoints Juan Graham...
Benzinga Newsdesk

Monday, November 25, 2024

RBC Capital Maintains Outperform on Perspecti...
Benzinga Newsdesk
B of A Securities Downgrades Perspective Ther...
Benzinga Newsdesk

Thursday, November 21, 2024

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Perspective Therapeutics shares are trading l...
Benzinga Newsdesk
Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
Avi Kapoor
Perspective Therapeutics Plans To Pursue Dose...
Benzinga Newsdesk
Perspective Therapeutics Announced Initial Re...
Benzinga Newsdesk

Friday, November 15, 2024

Perspective Therapeutics To Discuss Data On [...
Benzinga Newsdesk

Tuesday, November 12, 2024

Perspective Therapeutics Q3 2024 GAAP EPS $(0...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights

Wednesday, October 30, 2024

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Vandana Singh

Thursday, October 24, 2024

Wedbush Reiterates Outperform on Perspective ...
Benzinga Newsdesk
UBS Initiates Coverage On Perspective Therape...
Benzinga Newsdesk

Wednesday, October 23, 2024

Perspective Therapeutics Announced Six Update...
Benzinga Newsdesk

Wednesday, October 16, 2024

Perspective Therapeutics Announced The First ...
Benzinga Newsdesk

Friday, October 11, 2024

S&P 500 Moves Higher; BlackRock Reports Upbeat Results
Avi Kapoor
Oppenheimer Reiterates Outperform on Perspect...
Benzinga Newsdesk
Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings
Avi Kapoor
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
Vandana Singh

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved